Contact
searchSearch
HMP Global
Clinical Videos

Emergency Repair of Stent Misplacement in a False Lumen

Jingjing Chen, MD
Li Zhu, MD
12/03/2024

Video 1. The distal end of the aortic stent is inserted into the false lumen.

Video 2. Remedial measures after stent placement in the false lumen.

Video Supplement to "Emergency Repair of Stent Misplacement in a False Lumen" (Clinical Image).

© 2024 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Invasive Cardiology or HMP Global, their employees, and affiliates. 
 


News

ePRISM + Medis QFR
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care
12/10/2024
The use of Terumo Health Outcomes' ePRISM and Medis QFR will be piloted at selected clinical sites, leveraging real-time data from electronic health records to provide prospective insights to help enhance patient care.
The use of Terumo Health Outcomes' ePRISM and Medis QFR will be piloted at selected clinical sites, leveraging real-time data from electronic health records to provide prospective insights to help enhance patient care.
The use of Terumo Health...
12/10/2024
Cath Lab Digest
Pharmaceutical Therapy
Lilly's Zepbound (tirzepatide) Superior to Wegovy (semaglutide) in Head-to-Head Trial Showing Average Weight Loss of 20.2% vs 13.7%
12/04/2024
Results from the SURMOUNT-5 phase 3b open-label RCT: At 72 weeks, Zepbound beat Wegovy on both the primary endpoint and all 5 key secondary endpoints in this trial of adults living with obesity or overweight with at least one weight-related...
Results from the SURMOUNT-5 phase 3b open-label RCT: At 72 weeks, Zepbound beat Wegovy on both the primary endpoint and all 5 key secondary endpoints in this trial of adults living with obesity or overweight with at least one weight-related...
Results from the SURMOUNT-5...
12/04/2024
Cath Lab Digest
Mechanical Circulatory Support
New Research Shows That After Treatment With a Left Ventricular Assist Device, the Capacity of a Damaged Heart to Repair Itself With New Muscle Cells Becomes Significantly Higher
12/04/2024
Karolinska Institutet News After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving treatment with a supportive heart pump, the capacity of a damaged heart to repair itself...
Karolinska Institutet News After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving treatment with a supportive heart pump, the capacity of a damaged heart to repair itself...
Karolinska Institutet...
12/04/2024
Cath Lab Digest
Left to Right - Valentin Fuster, MD, PhD, President of Mount Sinai Fuster Heart Hospital and Physician-in-Chief of The Mount Sinai Hospital with Peter Libby, MD, President of the International Atherosclerosis Society. Photo credit: IAS 2024
Awards
Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society
12/04/2024
Among his many discoveries, Dr. Fuster identified that platelets play a role in coronary thrombosis and blockages. He was the first investigator to use aspirin in heart disease, specifically to prevent occlusion after bypass grafting.
Among his many discoveries, Dr. Fuster identified that platelets play a role in coronary thrombosis and blockages. He was the first investigator to use aspirin in heart disease, specifically to prevent occlusion after bypass grafting.
Among his many discoveries, Dr....
12/04/2024
Cath Lab Digest
Terumo R2P Navicross
Radial to Peripheral
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
12/03/2024
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P...
12/03/2024
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Adds Sixth Patent to Its Next-Generation IVL Portfolio
12/03/2024
"IVL has become a go-to tool for calcium modification and vessel preparation in large part due to its ease of use. I'm particularly excited about the potential of FastWave's IVL devices in critical areas like catheter deliverability and...
"IVL has become a go-to tool for calcium modification and vessel preparation in large part due to its ease of use. I'm particularly excited about the potential of FastWave's IVL devices in critical areas like catheter deliverability and...
"IVL has become a go-to tool for...
12/03/2024
Cath Lab Digest
Cardiogenic Shock
Cardiogenic Shock Team Cuts Time to Diagnosis by Half
12/02/2024
A nurse-led quality improvement initiative at the hospital significantly improved the time from first signs to diagnosis for patients already admitted and the time from the initial transfer request to acceptance for patients being transferred...
A nurse-led quality improvement initiative at the hospital significantly improved the time from first signs to diagnosis for patients already admitted and the time from the initial transfer request to acceptance for patients being transferred...
A nurse-led quality improvement...
12/02/2024
Cath Lab Digest
Transcatheter Aortic Valve Implantation
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
11/25/2024
This investigational Abbott TAVI system is the first step toward Abbott's software-guided balloon-expandable TAVI system and is designed to build a foundation for artificial intelligence (AI) guided procedures.
This investigational Abbott TAVI system is the first step toward Abbott's software-guided balloon-expandable TAVI system and is designed to build a foundation for artificial intelligence (AI) guided procedures.
This investigational Abbott TAVI...
11/25/2024
Cath Lab Digest
Atrial Fibrillation & Heart Failure
New Study Finds Atrial Fibrillation Common in Newly Diagnosed Heart Failure Patients, and Makes Prognosis Significantly Worse
11/25/2024
In the study, atrial fibrillation was present in 40% of all newly diagnosed heart failure patients. Patients with both heart failure and atrial fibrillation had an increased risk of death and a subsequent heart failure hospitalization when...
In the study, atrial fibrillation was present in 40% of all newly diagnosed heart failure patients. Patients with both heart failure and atrial fibrillation had an increased risk of death and a subsequent heart failure hospitalization when...
In the study, atrial...
11/25/2024
Cath Lab Digest
Cardiomyopathy
Attruby (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce CV Death and CV-Related Hospitalization in Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Patients
11/25/2024
The FDA approval is based on positive results seen in the ATTRibute-CM Phase 3 study, where Attruby significantly reduced death and cardiovascular-related hospitalization, and improved quality of life.
The FDA approval is based on positive results seen in the ATTRibute-CM Phase 3 study, where Attruby significantly reduced death and cardiovascular-related hospitalization, and improved quality of life.
The FDA approval is based on...
11/25/2024
Cath Lab Digest

ePRISM + Medis QFR
Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care
12/10/2024
The use of Terumo Health Outcomes' ePRISM and Medis QFR will be piloted at selected clinical sites, leveraging real-time data from electronic health records to provide prospective insights to help enhance patient care.
The use of Terumo Health Outcomes' ePRISM and Medis QFR will be piloted at selected clinical sites, leveraging real-time data from electronic health records to provide prospective insights to help enhance patient care.
The use of Terumo Health...
12/10/2024
Cath Lab Digest
Pharmaceutical Therapy
Lilly's Zepbound (tirzepatide) Superior to Wegovy (semaglutide) in Head-to-Head Trial Showing Average Weight Loss of 20.2% vs 13.7%
12/04/2024
Results from the SURMOUNT-5 phase 3b open-label RCT: At 72 weeks, Zepbound beat Wegovy on both the primary endpoint and all 5 key secondary endpoints in this trial of adults living with obesity or overweight with at least one weight-related...
Results from the SURMOUNT-5 phase 3b open-label RCT: At 72 weeks, Zepbound beat Wegovy on both the primary endpoint and all 5 key secondary endpoints in this trial of adults living with obesity or overweight with at least one weight-related...
Results from the SURMOUNT-5...
12/04/2024
Cath Lab Digest
Mechanical Circulatory Support
New Research Shows That After Treatment With a Left Ventricular Assist Device, the Capacity of a Damaged Heart to Repair Itself With New Muscle Cells Becomes Significantly Higher
12/04/2024
Karolinska Institutet News After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving treatment with a supportive heart pump, the capacity of a damaged heart to repair itself...
Karolinska Institutet News After severe heart failure, the ability of the heart to heal by forming new cells is very low. However, after receiving treatment with a supportive heart pump, the capacity of a damaged heart to repair itself...
Karolinska Institutet...
12/04/2024
Cath Lab Digest
Left to Right - Valentin Fuster, MD, PhD, President of Mount Sinai Fuster Heart Hospital and Physician-in-Chief of The Mount Sinai Hospital with Peter Libby, MD, President of the International Atherosclerosis Society. Photo credit: IAS 2024
Awards
Valentin Fuster, MD, PhD, Wins Prestigious Award From the International Atherosclerosis Society
12/04/2024
Among his many discoveries, Dr. Fuster identified that platelets play a role in coronary thrombosis and blockages. He was the first investigator to use aspirin in heart disease, specifically to prevent occlusion after bypass grafting.
Among his many discoveries, Dr. Fuster identified that platelets play a role in coronary thrombosis and blockages. He was the first investigator to use aspirin in heart disease, specifically to prevent occlusion after bypass grafting.
Among his many discoveries, Dr....
12/04/2024
Cath Lab Digest
Zhu Figure
Clinical Videos
Emergency Repair of Stent Misplacement in a False Lumen
12/03/2024
Video Supplement to "Emergency Repair of Stent Misplacement in a False Lumen" (Clinical Image).
Video Supplement to "Emergency Repair of Stent Misplacement in a False Lumen" (Clinical Image).
Video Supplement to "Emergency...
12/03/2024
Journal of Invasive Cardiology
Clinical Images
Emergency Repair of Stent Misplacement in a False Lumen
12/03/2024
A 55-year-old man with Stanford type B aortic dissection underwent thoracic aortic and left common carotid artery mulched stent implantation. He was admitted to our hospital after surgery with low urine output, and it was suspected that the...
A 55-year-old man with Stanford type B aortic dissection underwent thoracic aortic and left common carotid artery mulched stent implantation. He was admitted to our hospital after surgery with low urine output, and it was suspected that the...
A 55-year-old man with Stanford...
12/03/2024
Journal of Invasive Cardiology
Terumo R2P Navicross
Radial to Peripheral
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
12/03/2024
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P NaviCross catheter provides physicians performing percutaneous transluminal endovascular procedures from the radial artery a valuable tool to enhance their ability to safely and efficiently complete more...
“With the 200 cm length, the R2P...
12/03/2024
Cath Lab Digest
Intravascular Lithotripsy
FastWave Medical Adds Sixth Patent to Its Next-Generation IVL Portfolio
12/03/2024
"IVL has become a go-to tool for calcium modification and vessel preparation in large part due to its ease of use. I'm particularly excited about the potential of FastWave's IVL devices in critical areas like catheter deliverability and...
"IVL has become a go-to tool for calcium modification and vessel preparation in large part due to its ease of use. I'm particularly excited about the potential of FastWave's IVL devices in critical areas like catheter deliverability and...
"IVL has become a go-to tool for...
12/03/2024
Cath Lab Digest
Cardiogenic Shock
Cardiogenic Shock Team Cuts Time to Diagnosis by Half
12/02/2024
A nurse-led quality improvement initiative at the hospital significantly improved the time from first signs to diagnosis for patients already admitted and the time from the initial transfer request to acceptance for patients being transferred...
A nurse-led quality improvement initiative at the hospital significantly improved the time from first signs to diagnosis for patients already admitted and the time from the initial transfer request to acceptance for patients being transferred...
A nurse-led quality improvement...
12/02/2024
Cath Lab Digest
Ku Figure
Clinical Videos
A Rare Congenital Pulmonary Arteriovenous Fistula Presenting With Recurrent Headache And Dizziness
11/27/2024
Video Supplement to "A Rare Congenital Pulmonary Arteriovenous Fistula Presenting With Recurrent Headache And Dizziness" (Clinical Image).
Video Supplement to "A Rare Congenital Pulmonary Arteriovenous Fistula Presenting With Recurrent Headache And Dizziness" (Clinical Image).
Video Supplement to "A Rare...
11/27/2024
Journal of Invasive Cardiology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use